Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (456) 456
humans (434) 434
life sciences & biomedicine (430) 430
infectious diseases (301) 301
male (290) 290
female (255) 255
adult (253) 253
middle aged (243) 243
microbiology (226) 226
biological and medical sciences (169) 169
aged (165) 165
medical sciences (151) 151
taiwan (133) 133
immunology (132) 132
taiwan - epidemiology (120) 120
microbial sensitivity tests (95) 95
general & internal medicine (89) 89
aged, 80 and over (86) 86
medicine, general & internal (80) 80
infectious disease (78) 78
adolescent (77) 77
medicine (77) 77
risk factors (76) 76
retrospective studies (72) 72
anti-bacterial agents - pharmacology (67) 67
research (64) 64
infections (61) 61
prospective studies (60) 60
internal medicine (56) 56
bacterial diseases (53) 53
mortality (53) 53
treatment outcome (53) 53
fundamental and applied biological sciences. psychology (50) 50
health aspects (50) 50
medical education (48) 48
young adult (47) 47
human bacterial diseases (46) 46
immunology and allergy (44) 44
immunology and microbiology (44) 44
viral diseases (44) 44
anti-bacterial agents - therapeutic use (43) 43
pharmacology & pharmacy (43) 43
bacteremia - microbiology (42) 42
drug resistance (42) 42
human viral diseases (42) 42
pharmacology. drug treatments (42) 42
epidemiology (41) 41
bacteremia (40) 40
hiv (40) 40
miscellaneous (40) 40
antibiotics. antiinfectious agents. antiparasitic agents (39) 39
cross infection - microbiology (39) 39
incidence (39) 39
research article (39) 39
hiv infections - complications (38) 38
hiv infections - drug therapy (37) 37
hospitals (37) 37
abridged index medicus (36) 36
child (35) 35
care and treatment (34) 34
antibiotics (33) 33
bacteriology (32) 32
cross infection - epidemiology (32) 32
analysis (31) 31
multivariate analysis (31) 31
viral diseases of the lymphoid tissue and the blood. aids (31) 31
human immunodeficiency virus--hiv (29) 29
cross infection (28) 28
hospitals, university (28) 28
prognosis (28) 28
bacteremia - drug therapy (27) 27
child, preschool (27) 27
highly active antiretroviral therapy (27) 27
patients (27) 27
staphylococcal infections - microbiology (27) 27
antiretroviral therapy, highly active (26) 26
drug resistance, bacterial (26) 26
hiv infection (26) 26
infectious and parasitic diseases (26) 26
multidisciplinary sciences (26) 26
science & technology - other topics (26) 26
drug therapy (25) 25
medical colleges (25) 25
medical research (25) 25
nosocomial infections (25) 25
aids/hiv (24) 24
bacterial infections and mycoses (24) 24
bacterial sepsis (24) 24
biochemical phenomena, metabolism, and nutrition (24) 24
cd4 lymphocyte count (24) 24
genotype (24) 24
public, environmental & occupational health (24) 24
staphylococcus aureus (24) 24
virology (24) 24
aids (23) 23
science (23) 23
antibacterial agents (22) 22
bacteremia - mortality (22) 22
comorbidity (22) 22
dna, bacterial - genetics (22) 22
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Long-Acting Neuraminidase Inhibitor Laninamivir Octanoate versus Oseltamivir for Treatment of Influenza: A Double-Blind, Randomized, Noninferiority Clinical Trial
by Akira Watanabe and Shan-Chwen Chang and Min Ja Kim and Daniel Wai-sing Chu and Yasuo Ohashi and MARVEL Study Grp and MARVEL Study Group
Clinical infectious diseases, ISSN 1058-4838, 11/2010, Volume 51, Issue 10, pp. 1167 - 1175
H1N1 subtype influenza A virus | Influenza A virus | Viruses | Orthomyxoviridae | Infections | ARTICLES AND COMMENTARIES | Dosage | Caprylates | Symptoms | Diseases | Inhalation | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Antiviral agents | Viral diseases of the respiratory system and ent viral diseases | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Biological and medical sciences | Medical sciences | Human viral diseases | Antibiotics. Antiinfectious agents. Antiparasitic agents | Drug Administration Schedule | Administration, Oral | Influenza B virus - isolation & purification | Humans | Middle Aged | Administration, Inhalation | Male | Antiviral Agents - administration & dosage | Viral Load | Zanamivir - analogs & derivatives | Influenza A Virus, H1N1 Subtype - isolation & purification | Influenza A Virus, H3N2 Subtype - isolation & purification | Oseltamivir - administration & dosage | Zanamivir - administration & dosage | Adult | Female | Influenza, Human - virology | Aged | Influenza, Human - drug therapy | Oseltamivir phosphate | Dosage and administration | Enzyme inhibitors | Research | Drug therapy | Influenza | Clinical trials | Inhibitor drugs | Clinical outcomes | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Risk of aortic dissection and aortic aneurysm in patients taking oral fluoroquinolone
by Lee, Chien-Chang and Gabriel Lee, Meng-Tse and Chen, Yueh-Sheng and Lee, Shih-Hao and Chen, Yih-Sharng and Chen, Shyr-Chyr and Chang, Shan-Chwen
JAMA internal medicine, ISSN 2168-6106, 11/2015, Volume 175, Issue 11, pp. 1839 - 1847
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Aneurysm, Dissecting - epidemiology | Risk Assessment | Comorbidity | Aortic Aneurysm - epidemiology | Humans | Middle Aged | Risk Factors | Hospitalization - statistics & numerical data | Aortic Aneurysm - therapy | Male | Pharmacovigilance | Aneurysm, Dissecting - therapy | Case-Control Studies | Fluoroquinolones - adverse effects | Aortic Aneurysm - chemically induced | Aneurysm, Dissecting - chemically induced | Taiwan - epidemiology | Aged, 80 and over | Female | Aged | Anti-Bacterial Agents - adverse effects | Anti-Bacterial Agents - administration & dosage | Fluoroquinolones - administration & dosage
Journal Article
Details down arrow
3. Full Text Effect of daptomycin dose on the outcome of vancomycin-resistant, daptomycin-susceptible enterococcus faecium bacteremia
by Chuang, Yu-Chung and Li, Hsin-Yi and Chen, Pao-Yu and Lin, Chi-Ying and Wang, Jann-Tay and Chen, Yee-Chun and Chang, Shan-Chwen
Clinical infectious diseases, ISSN 1058-4838, 2017, Volume 64, Issue 8, pp. 1026 - 1034
mortality | daptomycin | dose | vancomycin-resistant enterococci | bacteremia | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Enterococcus faecium - drug effects | Prospective Studies | Vancomycin-Resistant Enterococci - drug effects | Humans | Middle Aged | Bacteremia - drug therapy | Gram-Positive Bacterial Infections - mortality | Bacteremia - mortality | Male | Treatment Outcome | Enterococcus faecium - isolation & purification | Bacteremia - microbiology | Microbial Sensitivity Tests | Young Adult | Vancomycin-Resistant Enterococci - isolation & purification | Gram-Positive Bacterial Infections - microbiology | Survival Analysis | Aged, 80 and over | Adult | Female | Aged | Gram-Positive Bacterial Infections - drug therapy | Anti-Bacterial Agents - administration & dosage | Daptomycin - administration & dosage | Enterococcal infections | Care and treatment | Infectious diseases | Regression analysis | Drug dosages | Medical treatment | Mortality | Clinical outcomes | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: Systematic review and meta-analysis
by Chuang, Yu-Chung and Wang, Jann-Tay and Lin, Hsin-Yi and Chang, Shan-Chwen
BMC infectious diseases, ISSN 1471-2334, 12/2014, Volume 14, Issue 1, pp. 687 - 687
Linezolid | Daptomycin | Meta-analysis | Vancomycin-resistant enterococci | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Vancomycin-Resistant Enterococci - drug effects | Humans | Bacteremia - drug therapy | Vancomycin Resistance | Acetamides - pharmacology | Treatment Outcome | Oxazolidinones - therapeutic use | Bacteremia - microbiology | Anti-Bacterial Agents - therapeutic use | Daptomycin - pharmacology | Acetamides - therapeutic use | Oxazolidinones - pharmacology | Vancomycin - therapeutic use | Vancomycin - pharmacology | Anti-Bacterial Agents - pharmacology | Retrospective Studies | Daptomycin - therapeutic use | Medical research | Drug resistance in microorganisms | Care and treatment | Mortality | Medicine, Experimental | Vancomycin | Comparative analysis | Health aspects | Studies | Medicine | Confidence intervals | Hospitals | Disease | Internal medicine | Bias | Bone marrow | Nosocomial infections | Drug therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Klebsiella pneumoniae Genotype K1: An Emerging Pathogen That Causes Septic Ocular or Central Nervous System Complications from Pyogenic Liver Abscess
by Chi-Tai Fang and Shau-Yan Lai and Wen-Ching Yi and Po-Ren Hsueh and Kao-Lang Liu and Shan-Chwen Chang
Clinical infectious diseases, ISSN 1058-4838, 8/2007, Volume 45, Issue 3, pp. 284 - 293
Pathogens | Eyes | Diabetes complications | Diabetes mellitus | Virulence | Articles and Commentaries | Liver abscess | Pyogenic liver abscess | Genotypes | Klebsiella pneumoniae | Visual perception | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Bacterial diseases of the digestive system and abdomen | Biological and medical sciences | Infectious diseases | Medical sciences | Bacterial diseases | Human bacterial diseases | Eye Infections, Bacterial - etiology | Central Nervous System Diseases - etiology | Disease Susceptibility | Humans | Klebsiella pneumoniae - genetics | Genotype | Liver Abscess, Pyogenic - microbiology | Klebsiella pneumoniae - classification | Central Nervous System Diseases - microbiology | Liver Abscess, Pyogenic - complications | Serotyping | Klebsiella | Complications and side effects | Care and treatment | Patient outcomes | Analysis | Endophthalmitis | Genetic aspects | Research | Genotype & phenotype | Bacteria | Nervous system | Infections | Liver diseases | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text The first case of H7N9 influenza in Taiwan
by Chang, Sui-Yuan and Lin, Pi-Han and Tsai, Jen-Chih and Hung, Chien-Ching and Chang, Shan-Chwen
The Lancet (British edition), ISSN 0140-6736, 2013, Volume 381, Issue 9878, pp. 1621 - 1621
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Influenza A virus - physiology | Humans | Middle Aged | Taiwan - epidemiology | Influenza, Human - epidemiology | Influenza, Human - virology | Male | Influenza, Human - transmission | Influenza, Human - therapy | Viral Load | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19: A Randomized Clinical Trial
by Spinner, Christoph D and Gottlieb, Robert L and Criner, Gerard J and Arribas López, José Ramón and Cattelan, Anna Maria and Soriano Viladomiu, Alex and Ogbuagu, Onyema and Malhotra, Prashant and Mullane, Kathleen M and Castagna, Antonella and Chai, Louis Yi Ann and Roestenberg, Meta and Tsang, Owen Tak Yin and Bernasconi, Enos and Le Turnier, Paul and Chang, Shan-Chwen and Sengupta, Devi and Hyland, Robert H and Osinusi, Anu O and Cao, Huyen and Blair, Christiana and Wang, Hongyuan and Gaggar, Anuj and Brainard, Diana M and McPhail, Mark J and Bhagani, Sanjay and Ahn, Mi Young and Sanyal, Arun J and Huhn, Gregory and Marty, Francisco M and GS-US-540-5774 Investigators
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 09/2020, Volume 324, Issue 11, pp. 1048 - 1057
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Alanine - therapeutic use | Pandemics | Alanine - adverse effects | Coronavirus Infections - drug therapy | Humans | Middle Aged | Pneumonia, Viral - drug therapy | Hospitalization - statistics & numerical data | Male | Coronavirus Infections - mortality | COVID-19 | Alanine - analogs & derivatives | Alanine - administration & dosage | SARS-CoV-2 | Betacoronavirus | Female | Odds Ratio | Drug Administration Schedule | Antiviral Agents - therapeutic use | Treatment Outcome | Adenosine Monophosphate - therapeutic use | Antiviral Agents - administration & dosage | Adenosine Monophosphate - adverse effects | Patient Acuity | Administration, Intravenous | Adenosine Monophosphate - administration & dosage | Adenosine Monophosphate - analogs & derivatives | Antiviral Agents - adverse effects | Aged | Pneumonia, Viral - mortality | Hypertension | Headache | Statistical analysis | Health services | Severe acute respiratory syndrome | Diabetes mellitus | Saturation | Viral diseases | Clinical trials | Nausea | Coronaviruses | Oxygen content | Patients | Severe acute respiratory syndrome coronavirus 2 | Respiratory diseases | Hypokalemia | Cardiovascular diseases | Significance
Journal Article
Details down arrow
8. Full Text Effectiveness of tigecycline-based versus colistin- based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumannii in a critical setting: A matched cohort analysis
by Chuang, Yu-Chung and Cheng, Chien-Yu and Sheng, Wang-Huei and Sun, Hsin-Yun and Wang, Jann-Tay and Chen, Yee-Chun and Chang, Shan-Chwen
BMC infectious diseases, ISSN 1471-2334, 02/2014, Volume 14, Issue 1, pp. 102 - 102
Acinetobacter baumannii | Pneumonia | Colistin | Tigecycline | Nephrotoxicity | Mortality | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Intensive Care Units | Humans | Middle Aged | Minocycline - analogs & derivatives | Acinetobacter Infections - drug therapy | Male | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Pneumonia - drug therapy | Minocycline - therapeutic use | Drug Resistance, Multiple, Bacterial | Taiwan | Aged, 80 and over | Adult | Colistin - therapeutic use | Female | Aged | Retrospective Studies | Acinetobacter baumannii - drug effects | Medicine | Intensive care | Hospitals | Antibiotics | Internal medicine | Older people | Infections | Drug resistance | Drug dosages | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Hepatitis A Outbreak Among Men Who Have Sex With Men in a Country of Low Endemicity of Hepatitis A Infection
by Chen, Guan-Jhou and Lin, Kuan-Yin and Hung, Chien-Ching and Chang, Shan-Chwen
The Journal of infectious diseases, ISSN 0022-1899, 04/2017, Volume 215, Issue 8, pp. 1339 - 1340
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Hepatitis A virus | Homosexuality, Male | Disease Outbreaks | Sexual and Gender Minorities | Humans | Vaccination | Male | Israel | Hepatitis A | Incidence | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Serologic responses and effectiveness of hepatitis A vaccination among human immunodeficiency virus–positive individuals during the outbreak of acute hepatitis A
by Lin, Kuan‐Yin and Hsieh, Szu‐Min and Sun, Hsin‐Yun and Lo, Yi‐Chun and Sheng, Wang‐Huei and Chuang, Yu‐Chung and Cheng, Aristine and Pan, Sung‐Ching and Chen, Guan‐Jhou and Hung, Chien‐Ching and Chang, Shan‐Chwen
Hepatology (Baltimore, Md.), ISSN 0270-9139, 07/2018, Volume 68, Issue 1, pp. 22 - 31
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | HIV Infections - immunology | Prospective Studies | Hepatitis A - epidemiology | Disease Outbreaks | Humans | Taiwan - epidemiology | Adult | Female | Male | Hepatitis A - prevention & control | Hepatitis A Vaccines - immunology | Antiretroviral drugs | Immunization | Immunoglobulin G | Vaccination | Outbreaks | Infections | Vaccines | Ribonucleic acid--RNA | Seroconversion | Antiretroviral therapy | CD4 antigen | Confidence intervals | Hepatitis | Motivation | Human immunodeficiency virus--HIV | Hepatitis A | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Emergence of extensively drug-resistant Acinetobacter baumannii complex over 10 years: Nationwide data from the Taiwan Surveillance of Antimicrobial Resistance (TSAR) program
by Kuo, Shu-Chen and Chang, Shan-Chwen and Wang, Hui-Ying and Lai, Jui-Fen and Chen, Pei-Chen and Shiau, Yih-Ru and Huang, I-Wen and Lauderdale, Tsai-Ling Y and TSAR Hosp and TSAR Hospitals
BMC infectious diseases, ISSN 1471-2334, 08/2012, Volume 12, Issue 1, pp. 200 - 200
Extensively drug-resistant | Acinetobacter baumannii complex | Antimicrobial resistance | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Humans | Middle Aged | Male | Incidence | Microbial Sensitivity Tests | Hospitals | Acinetobacter Infections - epidemiology | Cross Infection - microbiology | Drug Resistance, Multiple, Bacterial | Taiwan - epidemiology | Aged, 80 and over | Acinetobacter baumannii - isolation & purification | Adult | Female | Aged | Anti-Bacterial Agents - pharmacology | Acinetobacter baumannii - drug effects | Longitudinal Studies | Acinetobacter Infections - microbiology | Cross Infection - epidemiology | Infection | Drug resistance in microorganisms | Acinetobacter baumannii | Aminoglycosides | Beta lactamases | Research | Health aspects | Antibacterial agents | Medicine | Medical research | Mortality | Antimicrobial agents | Infections | Drug resistance | Manuscripts | Teaching hospitals | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights